Prescription drug abuse is a well-documented problem. In 2019 alone, there were nearly 71 000 drug overdose-related deaths recorded in the United States, and many of these overdoses involved the use of prescription opioids, stimulants, or sedatives. 1 To combat this issue, many states have established prescription drug monitoring programs and instituted mandatory checks of the resulting databases prior to prescribing drugs with abuse potential. These databases provide a patient-